Sphera Funds Management Ltd. Lava Therapeutics Nv Transaction History
Sphera Funds Management Ltd.
- $638 Million
- Q1 2024
A detailed history of Sphera Funds Management Ltd. transactions in Lava Therapeutics Nv stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 367,582 shares of LVTX stock, worth $694,729. This represents 0.19% of its overall portfolio holdings.
Number of Shares
367,582Holding current value
$694,729% of portfolio
0.19%Shares
5 transactions
Others Institutions Holding LVTX
# of Institutions
26Shares Held
3.76MCall Options Held
28KPut Options Held
43.4K-
Redmile Group, LLC San Francisco, CA2.07MShares$3.92 Million0.27% of portfolio
-
Bruce & Co., Inc. Chicago, IL772KShares$1.46 Million1.27% of portfolio
-
Walleye Capital LLC Plymouth, MN155KShares$292,3180.0% of portfolio
-
Alpha Wave Global, LP New York, NY108KShares$203,9420.2% of portfolio
-
Two Sigma Investments, LP New York, NY82KShares$155,0380.0% of portfolio
About LAVA Therapeutics NV
- Ticker LVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,797,700
- Market Cap $48.8M
- Description
- LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...